Publication | Closed Access

Glycyrrhizin Treatment Is Associated with Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression

InflammationAcute Lung InjuryAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineRespiratory ToxicologyPulmonary PharmacologyPharmacologyPulmonary DiseaseOxidative Stress